17/12/2024 – AB Science provides a summary of the webcast held on December 16, 2024

16/12/2024 – Presentation of the AB Science webcast held on December 16, 2024

11/12/2024 – AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

28/10/2024 – AB Science today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating sickle cell disease with masitinib

17/10/2024 – AB Science today announces that the European Medicines Agency (EMA) confirmed a negative opinion for the conditional marketing authorization of masitinib in the treatment of amyotrophic lateral sclerosis

10/10/2024 – AB Science today reports its revenues for the first half of 2024 and provides an update on its activities